Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Romosozumab Promising for Osteoporosis Treatment; Setbacks for Fulranumab Clinical Trials

Michele B. Kaufman, PharmD, BCGP  |  April 27, 2016

Two studies have shown that romosozumab is effective for increasing bone mineral density in both men and women with osteoporosis. And due to safety concerns, Janssen has dropped out of clinical trials for fulranumab, which is being studied to treat OA pain…

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:menOsteoporosisromosozumabWomen

Abaloparatide May Boost BMD in Older Women with Osteoporosis

Lorraine L. Janeczko  |  April 26, 2016

NEW YORK (Reuters Health)—The investigational drug abaloparatide may help postmenopausal women increase their bone mineral density (BMD) and reduce their risk of fracture, new industry research suggests. “What was surprising and very important about this study was that, although some drugs for osteoporosis don’t work across all patient subgroups, abaloparatide provided persistent protection against fracture…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:abaloparatidebone mineral density (BMD)Osteoporosisosteoporosis treatmentspostmenopauseWomen

Innate Immune Response Enters Center Stage for Inflammatory Eye Disease

Lara C. Pullen, PhD  |  April 25, 2016

Researchers suspect the C-type lectin receptor (CLR) mincle may play a role in experimental autoimmune uveoretinitis. A new study linked CLR mincle to Card9-signaling events and IL-1, resulting in inflammation…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:InfectionInflammatory Eye DiseaseUveitis

Technological Advances Linked to Medical Misadventures

Simon M. Helfgott, MD  |  April 15, 2016

For keen students of American politics, the unending intrigue of the 2016 presidential race has been riveting. With an assemblage of aspiring candidates that, at its start, included a bevy of U.S. senators and former governors, a media-savvy real estate mogul, a renowned Hopkins neurosurgeon and an ophthalmologist, political junkies among us have feasted on…

Filed under:OpinionPractice SupportQuality Assurance/ImprovementRheuminationsSpeak Out RheumTechnology Tagged with:dataEHRelectronic health recordmedical errorphysicianPractice ManagementQualityrheumatologistTechnology

Practicing Mindfulness Can Help Alter Patients’ Experience With Chronic Rheumatic Diseases

Practicing Mindfulness Can Help Alter Patients’ Experience with Chronic Rheumatic Diseases

C. Ronald MacKenzie, MD  |  April 15, 2016

Mindfulness is a mental state achieved by focusing one’s awareness on the present moment, while acknowledging and non-judgmentally accepting one’s feelings, thoughts and bodily sensations. Known in Sanskrit as smrti, meaning “to remember,” in Pali, the language of early Buddhist scriptures, it is recognized by the word sati (mindfulness).1 Derived from ancient meditative Buddhist disciplines,…

Filed under:ConditionsPain SyndromesPractice SupportQuality Assurance/Improvement Tagged with:FibromyalgiaManagementmindfulnessPainpatient careRheumatic DiseaseRheumatoid arthritisStress

Rheumatology Research Foundation Creates Five-Year Strategic Plan

From the College  |  April 15, 2016

Dramatic advancements in research toward prevention and cure are at risk, as federal research funding for rheumatic diseases has declined by 40% over the past five years. With that, an alarming number of rheumatologists are preparing for retirement. To stop this worrying trend, a strategic plan for the next five years was developed to complement…

Filed under:From the CollegeResearch Rheum Tagged with:AC&RAdvocacyAmerican College of Rheumatology (ACR)Rheumatology Research FoundationStrategy

6 Tips for Writing a Good Clinical Case Report

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  April 15, 2016

“That’s a great case. Why don’t we write it up?” It’s a question I’ve heard many times throughout medical school, residency and fellowship. It’s typically intended to be more of a politely worded request than a rhetorical question. We must acknowledge that the process of writing, editing and submitting a case report is onerous, but it…

Filed under:From the CollegePractice Support Tagged with:case reportClinicalfellowmedical studentphysicianrheumatologytips

Rheumatology Coding Corner Answer: Coding & Billing Basics

From the College  |  April 15, 2016

Take the challenge. 1. D: All of the above Rationale: Per CPT, if time spent counseling and/or coordinating care dominates the session, then total time must be documented; greater than 50% of the time must be for face-to-face counseling and/or coordinating care, and must be documented as such. Additionally, the extent of the counseling and/or…

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingPractice Managementrheumatologistrheumatology

The ACR, ARHP Develop National Research Agenda for 2016–2020

From the College  |  April 15, 2016

Since 2005, the ACR’s Committee on Research has been responsible for advancing the research goals of the organization and providing leadership in research and research training in rheumatology via the ACR’s Research Agenda. The ACR Research Agenda is designed to address critical areas of research in rheumatic diseases, including the need for new technology, new…

Filed under:From the CollegeResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)Association of Rheumatology Professionals (ARP)Research

Research Provides Insight into Impact of Microbiome on Health, Rheumatic Disease

Neha Ohri, MD, & Kristine A. Kuhn, MD, PhD  |  April 15, 2016

The microbiome comprises diverse microbial flora, including bacteria, viruses and fungi, that live on mucosal surfaces, predominantly the skin and digestive tract. Microbes evolved billions of years prior to the development of modern Homo sapiens 200,000 years ago; we have always existed with their ubiquitous presence. Despite this, the first microbe was not visualized until…

Filed under:Axial SpondyloarthritisConditionsResearch RheumRheumatoid Arthritis Tagged with:gastrointestinalhealthmicrobialMicrobiomemicrobiotiaResearchRheumatic Disease

  • « Previous Page
  • 1
  • …
  • 222
  • 223
  • 224
  • 225
  • 226
  • …
  • 330
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences